Anders Jack 4
4 · Revolution Medicines, Inc. · Filed Nov 13, 2025
Insider Transaction Report
Form 4
Anders Jack
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2025-11-11$17.00/sh+10,000$170,000→ 120,994 total - Sale
Common Stock
2025-11-11$64.00/sh−10,000$640,000→ 110,994 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-11-11−10,000→ 5,418 totalExercise: $17.00From: 2024-02-12Exp: 2030-02-11→ Common Stock (10,000 underlying)
Footnotes (2)
- [F1]Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 16, 2024.
- [F2]Includes 48,275 restricted stock units.